Antinociceptive synergy between Δ9-tetrahydrocannabinol and opioids after oral administration

Journal of Pharmacology and Experimental Therapeutics

Volumn 304, Issue 3, 2003, Pages 1010-1015

  Cichewicz, Diana L ^a   McCarthy, Erin A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; CODEINE; DRONABINOL; MORPHINE; OPIATE;

ANALGESIA; ANIMAL EXPERIMENT; ANTINOCICEPTION; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG POTENTIATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; TAIL FLICK TEST;

ADMINISTRATION, ORAL; ANALGESICS; ANIMALS; CODEINE; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; MALE; MICE; MICE, INBRED ICR; MORPHINE; NARCOTICS; PAIN; TETRAHYDROCANNABINOL;

EID: 0037373238     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.102.045575     Document Type: Article

References (40)

1. Bhargava HN (1980) The effects of thyrotropin releasing hormone and histidylproline diketopiperazine on delta-9-tetrahydrocannabinol-induced hypothermia. Life Sci 26:845-850.
2. Bidaut-Russell M and Howlett A (1988) Opioid and cannabinoid analgetics both inhibit cyclic AMP production in the rat striatum, in Advances in the Biosciences: Proceedings of the International Narcotics Research Conference (Hamon M and Meunier J eds), Pergamon Press, Oxford.
3. Bloom AS and Dewey WL (1978) A comparison of some pharmacological actions of morphine and δ9-tetrahydrocarmabinol in the mouse. Psychopharmacology (Berl) 57:243-248.
4. Cichewicz DL, Martin ZL, Smith FL, and Welch SP (1999) Enhancement of μ opioid antinociception by oral δ9-tetrahydrocannabinol: dose-response analysis and receptor identification. J Pharmacol Exp Ther 289:859-867.
5. Corchero J, Avila MA, Fuentes JA, and Manzaneres J (1997) Delta 9-tetrahydrocannabinol increases prodynorphin and proenkephalin gene expression in the spinal cord of the rat. Life Sci 61:PL39-PL43.
6. D'Amour FE and Smith DL (1941) A method for determining loss of pain sensation. J Pharmacologie 72:74-79.
7. Gomes I, Jordan BA, Gupta A, Trapaidze N, Nagy V, and Devi LA (2000) Heterodimerization of μ and δ opioid receptors: a role in opiate synergy. J Neurosci 20:RC110.
8. Harris LS and Pierson AK (1964) Some narcotic antagonists in the benzomorphan series. J Pharmacol Exp Ther 143:141-148.
9. Holtzman D, Lovell RA, Jaffe JH, and Freedman DX (1969) 1-delta9-tetrahydrocannabinol: neurochemical and behavioral effects in the mouse. Science (Wash DC) 163:1464-1467.
10. Kimmel HL, Tallarida RJ, and Holtzman SG (1997) Synergism between buprenorphine and cocaine on the rotational behavior of the nigrally-lesioned rat. Psychopharmacology (Berl) 133:372-377.
11. Kolesnikov YA, Chereshnev I, and Pasternak GW (2000) Analgesic synergy between topical lidocaine and topical opioids. J Pharmacol Exp Ther 295:546-551.
12. Kuhar MJ, Pert CB, and Snyder SH (1973) Regional distribution of opiate receptor binding in monkey and human brain. Nature (Lond) 245:447-450.
13. Mailleux P and Vanderhaeghen JJ (1992) Localization of cannabinoid receptor in the human developing and adult basal ganglia: higher levels in the striatonigral neurons. Neurosci Lett 148:173-176.
14. Manzaneres J, Corchero J, Romero JJ, Fernandez-Ruiz JA, Ramos JA, and Fuentes JA (1999) Pharmacological and biochemical interactions between opioids and cannabinoids. Trends Pharmacol Sci 20:287-294.
15. Miaskowski C, Sutters KA, Taiwo YO, and Levine JD (1992) Antinociceptive and motor effects of delta/mu and kappa/mu combinations of intrathecal opioid agonists. Pain 49:137-144.
16. Neil A (1984) Affinities of some common opioid analgesics towards four binding sites in mouse brain. Naunyn-Schmiedberg's Arch Pharmacol 328:24-29.
17. Pasternak GW (1993) Pharmacological mechanisms of opioid analgesics. Clin Neuropharmacol 16:1-18.
18. Pugh G Jr, Smith P, Dombrowski D, and Welch SP (1996) The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-THC and morphine in the spinal cord. J Pharmacol Exp Ther 279:608-616.
19. Pugh G Jr, Welch SP, and Bass PP (1994) Modulation of free intracellular calcium and cAMP by morphine and cannabinoids, alone and in combination in mouse brain and spinal cord synaptosomes. Pharmacol Biochem Behav 49:1093-1100.
20. Raffa RB, Friderichs E, Reimann W, Shank RP, Codd EE, Vaught JL, Jacoby HI, and Selve N (1993) Complementary and synergistic antinociceptive interaction between the enantiomers of tramadol. J Pharmacol Exp Ther 267:331-340.
21. Reche I, Fuentes JA, and Ruiz-Gayo M (1996) Potentiation of Δ9-tetrahydrocannabinol-induced analgesia by morphine in mice: involvement of μ- and κ-opioid receptors. Eur J Pharmacol 318:11-16.
22. Roerig SC, Hoffman RG, Takemori AE, Wilcox GL, and Fujimoto JM (1991) Isobolographic analysis of analgesic interactions between intrathecally and intracerebroventricularly administered fentanyl, morphine and D-Ala2-D-Leu5-enkephalin in morphine-tolerant and nontolerant mice. J Pharmacol Exp Ther 257:1091-1099.
23. Roth JD and Rowland NE (1999) Anorectic efficacy of the fenfiuramine/phentermine combination in rats: additivity or synergy? Eur J Pharmacol 373:127-134.
24. Rothman RB and Westfall TC (1982) Allosteric coupling between morphine and enkephalin receptors in vitro. Mol Pharmacol 21:548-557.
25. Smith FL, Cichewicz D, Martin ZL, and Welch SP (1998) The enhancement of morphine antinociception by Δ9-tetrahydrocannabinol. Pharmacol Biochem Behav 60:559-566.
26. Smith PB, Welch SP, and Martin BR (1994) Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice. J Pharmacol Exp Ther 268:1382-1387.
27. 5]enkephalin-induced analgesia. Eur J Pharmacol 324:R1-R2.
28. Sutters KA, Miaskowski C, Taiwo YO, and Levine JD (1990) Analgesic synergy and improved motor function produced by combinations of mu-delta and mu-kappa opioids. Brain Res 530:290-294.
29. Tallarida RJ (2000) Equations 4.9 and 4.10, in Drug Synergism and Dose-Effect Data Analysis, pp 61-62, Chapman & Hall/CRC, New York.
30. Tallarida RJ (2001) Drug synergism: its detection and applications. J Pharmacol Exp Ther 298:865-872.
31. Tallarida RJ, Kimmel HL, and Holtzman SG (1997) Theory and statistics of detecting synergism between two active drugs: cocaine and buprenorphine. Psychopharmacology 133:378-382.
32. Tallarida RJ and Murray RB (1987) Procedures 6, 8, 9, 11, in Manual of Pharmacologic Calculations with Computer Programs, Springer-Verlag, New York.
33. Thorat SN and Bhargava HN (1994) Evidence for a bidirectional cross-tolerance between morphine and Δ9-tetrahydrocannabinol in mice. Eur J Pharmacol 260: 5-13.
34. Traynor J and Elliot J (1993) δ-opioid receptor subtypes and cross-talk with μ-receptors. Trends Pharmacol Sci 14:84-86.
35. Vaught JL, Rothman RB, and Westfall TC (1982) Mu and delta receptors: their role in analgesia and in the differential effects of opioid peptides on analgesia. Life Sci 30:1443-1455.
36. Welch SP (1993) Modulation of cannabinoid-induced antinociception by norbinaltorphimine, but not ICI 174, 864, in mice. J Pharmacol Exp Ther 265:633-640.
37. Welch SP and Eades M (1999) Synergistic interactions of endogenous opioids and cannabinoid systems. Brain Res 848:183-190.
38. Welch SP and Stevens DL (1992) Antinociceptive activity of intrathecally administered cannabinoids alone and in combination with morphine, in mice. J Pharmacol Exp Ther 262:10-18.
39. Wellman PJ, Tow S, and McMahon L (1995) Isobolographic assessment of the effects of combinations of phenylpropanolamine and fenfluramine on food intake in rats. Pharmacol Biochem Behav 50:287-291.
40. Wessinger WD (1986) Approaches to the study of drug interactions in behavioral pharmacology. Neurosci Biobehav Rev 10:103-113.